Does SACUBITRIL\VALSARTAN Cause Lung opacity? 21 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Lung opacity have been filed in association with SACUBITRIL\VALSARTAN. This represents 0.0% of all adverse event reports for SACUBITRIL\VALSARTAN.
21
Reports of Lung opacity with SACUBITRIL\VALSARTAN
0.0%
of all SACUBITRIL\VALSARTAN reports
1
Deaths
10
Hospitalizations
How Dangerous Is Lung opacity From SACUBITRIL\VALSARTAN?
Of the 21 reports, 1 (4.8%) resulted in death, 10 (47.6%) required hospitalization.
Is Lung opacity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SACUBITRIL\VALSARTAN. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does SACUBITRIL\VALSARTAN Cause?
Hypotension (11,718)
Death (9,605)
Dyspnoea (8,952)
Dizziness (8,548)
Fatigue (8,172)
Wrong technique in product usage process (8,022)
Cough (7,743)
Weight decreased (5,030)
Cardiac failure (4,504)
Malaise (4,299)
What Other Drugs Cause Lung opacity?
ALBUTEROL (296)
PREDNISONE (216)
TIOTROPIUM (196)
LANSOPRAZOLE (166)
IPRATROPIUM (157)
ACETAMINOPHEN (153)
MEPOLIZUMAB (149)
PANTOPRAZOLE (140)
BUDESONIDE\FORMOTEROL (139)
MONTELUKAST (137)
Which SACUBITRIL\VALSARTAN Alternatives Have Lower Lung opacity Risk?
SACUBITRIL\VALSARTAN vs SAFINAMIDE
SACUBITRIL\VALSARTAN vs SAIZEN
SACUBITRIL\VALSARTAN vs SALICYLATE
SACUBITRIL\VALSARTAN vs SALICYLIC ACID
SACUBITRIL\VALSARTAN vs SALMETEROL